Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target
Stefano Pierini(Carisma Therapeutics (United States)), Andrea Facciabene(Hospital of the University of Pennsylvania)
Cited by 27
Related Papers
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
|Nature Medicine|2022|308
Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response
|Journal of Clinical Investigation|2019|295
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
|JCI Insight|2018|167
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
|Nature Communications|2025|80
Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature
|Journal of Clinical Investigation|2014|73